Cargando…

Factors influencing adherence to an app-based exercise program in adolescents with painful hyperkyphosis

BACKGROUND: Software applications (apps) could potentially promote exercise adherence. However, it is unclear whether adolescents with painful hyperkyphosis will use an app designed for a home exercise program. The purpose of this study is to assess factors regarding adherence to an app-based home e...

Descripción completa

Detalles Bibliográficos
Autores principales: Zapata, Karina A., Wang-Price, Sharon S., Fletcher, Tina S., Johnston, Charles E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050689/
https://www.ncbi.nlm.nih.gov/pubmed/30027121
http://dx.doi.org/10.1186/s13013-018-0159-x
Descripción
Sumario:BACKGROUND: Software applications (apps) could potentially promote exercise adherence. However, it is unclear whether adolescents with painful hyperkyphosis will use an app designed for a home exercise program. The purpose of this study is to assess factors regarding adherence to an app-based home exercise program in adolescents with hyperkyphosis and back pain who were provided a one-time exercise treatment. METHODS: Twenty-one participants were instructed in a one-time exercise treatment and asked to complete a home exercise program 3 times a week for 6 months using an app called PT PAL. At a 6-month follow-up, 14 participants completed a survey assessing factors related to their experiences using the app and their treatment engagement. RESULTS: Although most participants did not use the app, they reported performing their exercises a few times per week. The adolescent participants considered the app to be more of a barrier than a supportive measure for promoting exercise adherence. Most participants still reported bothersome back pain. CONCLUSIONS: Although adherence to the 6-month app-based home exercise program was not successful, adolescents still viewed technology support such as text reminders as a potential solution. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03212664. Registered 11 July 2017. Retrospectively registered.